Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Ann Pharmacother. 2021 Sep 7;56(6):645–655. doi: 10.1177/10600280211043278

Table 4.

Outcomes Per Patient on Sleep Protocol and All Admission Days.

Preimplementation (n = 78) Postimplementation (n = 84) P value

Outcomes evaluated on sleep protocol days
 Median number of delirium-free days [IQR] 1 [0–2.5]a 1 [0–2]b 0.48
 Median RCSQ score [IQR] 59.4 [43.2–71.6]c 61.2 [49.9–75.5]c 0.20
 Median number of optimal sleep nights [IQR] 1 [0–2]c 1 [0–2]c 0.95
Outcomes evaluated on all admission days
 Median duration of MV, days [IQR] 8 [4–10]d 4 [2–7]d 0.03
 Median duration of MV, days [IQR], excluding mortality patients 7 [3–9]e 3 [2–5]f 0.01
 Median ICU length of stay, days [IQR] 5.5 [4–10] 4 [3–7] 0.10
 Median ICU length of stay, days [IQR], excluding mortality patients 5 [3.5–8.5]g 4 [3–6]a 0.12
 Median hospital length of stay, days [IQR] 13 [7–22.3] 8 [6–17] 0.05
 Median hospital length of stay, days [IQR], excluding mortality patients 15 [7–23.5]g 8 [6–15]a 0.02
 In-hospital mortality, n (%) 13 (16.7) 15 (17.9) 1.00

Abbreviations: ICU, intensive care unit; IQR, interquartile range; MV, mechanical ventilation; RCSQ, Richards-Campbell Sleep Questionnaire.

a

n = 69.

b

n = 80.

c

n = 74.

d

n = 35.

e

n = 27.

f

n = 25.

g

n = 65.